Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2013

Chadburn A, Abdul-Nabi AM, Teruya BS, Lo AA. Lymphoid proliferations associated with human immunodeficiency virus infection. Arch Pathol Lab Med. 2013;137(3):360-70.

Rink M, Park K, Volkmer BG, Xylinas E, Hansen J, Cha EK, et al. Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy. Urol Oncol. 2013;31(8):1716-24.

Greenblatt MB, Shim J-. Osteoimmunology: a brief introduction. Immune Netw. 2013;13(4):111-5.

Vakifahmetoglu-Norberg H, Kim M, Xia H-, Iwanicki MP, Ofengeim D, Coloff JL, et al. Chaperone-mediated autophagy degrades mutant p53. Genes Dev. 2013;27(15):1718-30.

Rodríguez-Ayala G, de la Vega A, Correa-Rivas M, Jimenez A. Chorioangioma: an uncommon cause of hydramnios and consequent preterm labor in second trimester of pregnancy. Bol Asoc Med P R. 2013;105(1):36-9.

Beltran H, Yelensky R, Frampton GM, Park K, Downing SR, MacDonald TY, et al. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. Eur Urol. 2013;63(5):920-6.

Piotti KC, Scognamiglio T, Chiu R, Chen Y-. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia. Pathol Res Pract. 2013;209(11):721-6.

Martz J, Jain S, Vahdat LT, Qin L, Mosquera JM, Antonescu CR, et al. High-grade KIT-negative sarcoma of the small bowel in a patient with chronic myeloid leukemia receiving long-term tyrosine kinase inhibitors. J Clin Oncol. 2013;31(11):e181-5.

Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, et al. Gleason grade progression is uncommon. Cancer Res. 2013;73(16):5163-8.

Flacke J-, Flacke H, Appukuttan A, Palisaar R-, Noldus J, Robinson BD, et al. Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells. J Biol Chem. 2013;288(5):3126-35.